Cellular and Molecular Neuroscience, Biochemistry, Genetics and Molecular Biology, Biological Psychiatry, Animal Science and Zoology
25
Scopus Publications
513
Scholar Citations
13
Scholar h-index
18
Scholar i10-index
Scopus Publications
Gut dysbiosis in neurodevelopmental disorders: linking microbiota signatures to cognitive rigidity in autism spectrum disorder Bhagavathi Sundaram Sivamaruthi, Periyanaina Kesika, Chaiyavat Chaiyasut, Durairaj Ragu Varman Frontiers in Microbiology, 2026 Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition characterised not only by social-communication difficulties but also by restricted interests, stereotyped behaviours, and marked cognitive rigidity. Over the past decade, converging lines of evidence have implicated gut dysbiosis, an imbalance in intestinal microbial composition and function, as a potentially important modulator of these behavioural phenotypes via the microbiota-gut-brain axis. In this narrative review, we integrate preclinical and clinical data to examine how specific microbial signatures, metabolic pathways, and immune and synaptic mechanisms may contribute to inflexible cognition in ASD. The manuscript outlines the organisation of the microbiota gut-brain axis in neurodevelopment and summarises reproducible microbial alterations reported in ASD cohorts. We then discuss how microbial metabolites, including short-chain fatty acids and tryptophan-derived neuroactive molecules, as well as immune mediators and neurotransmitter precursors, converge on pathways regulating excitatory-inhibitory balance, synaptic plasticity, and corticostriatal circuit function. Evidence from germ-free, genetic, and environmental rodent models provides causal support for microbiota-dependent modulation of repetitive and rigid behaviours, whilst clinical studies reveal associations between dysbiosis, metabolomic profiles, gastrointestinal symptoms, and ASD severity. Finally, we consider the translational landscape of microbiota-targeted interventions, probiotics, prebiotics, dietary strategies, and faecal microbiota transplantation and highlight key methodological and ethical challenges for moving toward precision microbiome-based therapies. Taken together, current data support gut dysbiosis as both a mechanistic contributor and a tractable therapeutic target for cognitive rigidity in ASD.
Spontaneous Calcium Transients Recorded from Striatal Astrocytes in a Preclinical Model of Autism Hugo Saavedra-Bonilla, Durairaj Ragu Varman, Daniel Reyes-Haro Neurochemical Research, 2024 Autism spectrum disorder (ASD) is known as a group of neurodevelopmental conditions including stereotyped and repetitive behaviors, besides social and sensorimotor deficits. Anatomical and functional evidence indicates atypical maturation of the striatum. Astrocytes regulate the maturation and plasticity of synaptic circuits, and impaired calcium signaling is associated with repetitive behaviors and atypical social interaction. Spontaneous calcium transients (SCT) recorded in the striatal astrocytes of the rat were investigated in the preclinical model of ASD by prenatal exposure to valproic acid (VPA). Our results showed sensorimotor delay, augmented glial fibrillary acidic protein -a typical intermediate filament protein expressed by astrocytes- and diminished expression of GABAA-ρ3 through development, and increased frequency of SCT with a reduced latency that resulted in a diminished amplitude in the VPA model. The convulsant picrotoxin, a GABAA (γ-aminobutyric acid type A) receptor antagonist, reduced the frequency of SCT in both experimental groups but rescued this parameter to control levels in the preclinical ASD model. The amplitude and latency of SCT were decreased by picrotoxin in both experimental groups. Nipecotic acid, a GABA uptake inhibitor, reduced the mean amplitude only for the control group. Nevertheless, nipecotic acid increased the frequency but diminished the latency in both experimental groups. Thus, we conclude that striatal astrocytes exhibit SCT modulated by GABAA-mediated signaling, and prenatal exposure to VPA disturbs this tuning.
Neurokinin-1 Antagonism Distinguishes the Role of Norepinephrine Transporter from Dopamine Transporter in Mediating Amphetamine Behaviors Padmanabhan Mannangatti, Durairaj Ragu Varman, Sammanda Ramamoorthy, Lankupalle D. Jayanthi Pharmacology, 2021 <b><i>Background:</i></b> Amphetamine (AMPH) and other psychostimulants act on the norepinephrine (NE) transporter (NET) and the dopamine (DA) transporter (DAT) and enhance NE and DA signaling. Both NET and DAT share anatomical and functional characteristics and are regulated similarly by psychostimulants and receptor-linked signaling pathways. We and others have demonstrated that NET and DAT are downregulated by AMPH and substance P/neurokinin-1 receptor (NK1R)-mediated protein kinase C pathway. <b><i>Objectives:</i></b> Since both NET and DAT are downregulated by AMPH and NK1R activation and share high sequence homology, the objective of the study was to determine the catecholamine transporter specificity in NK1R modulation of AMPH-induced behaviors. <b><i>Methods:</i></b> The effect of NK1R antagonism on AMPH-induced conditioned place preference (CPP) as well as AMPH-induced NET and DAT downregulation was examined using NET and DAT knockout mice (NET-KO and DAT-KO) along with their wild-type littermates. <b><i>Results:</i></b> Aprepitant (5 mg/kg i.p.) significantly attenuated AMPH (2 mg/kg i.p.)-induced CPP in the wild-type and DAT-KO but not in the NET-KO. Locomotor activity measured during the post-conditioning test (in the absence of AMPH) showed higher locomotor activity in DAT-KO compared to wild-type or NET-KO. However, the locomotor activity of all 3 genotypes remained unchanged following aprepitant. Additionally, in the ventral striatum of wild-type, the AMPH-induced downregulation of NET function and surface expression but not that of DAT was attenuated by aprepitant. <b><i>Conclusions:</i></b> The results from the current study demonstrate that aprepitant attenuates the expression of AMPH-induced CPP in DAT-KO mice but not in NET-KO mice suggesting a role for NK1R-mediated NET regulation in AMPH-induced behaviors.
Glycogen synthase kinase-3ß supports serotonin transporter function and trafficking in a phosphorylation-dependent manner Durairaj Ragu Varman, Lankupalle D. Jayanthi, Sammanda Ramamoorthy Journal of Neurochemistry, 2021 Serotonin (5‐HT) transporter (SERT) plays a crucial role in serotonergic transmission in the central nervous system, and any aberration causes serious mental illnesses. Nevertheless, the cellular mechanisms that regulate SERT function and trafficking are not entirely understood. Growing evidence suggests that several protein kinases act as modulators. Here, we delineate the molecular mechanisms by which glycogen synthase kinase‐3ß (GSK3ß) regulates SERT. When mouse striatal synaptosomes were treated with the GSK3α/ß inhibitor CHIR99021, we observed a significant increase in SERT function, Vmax, surface expression with a reduction in 5‐HT Km and SERT phosphorylation. To further study how the SERT molecule is affected by GSK3α/ß, we used HEK‐293 cells as a heterologous expression system. As in striatal synaptosomes, CHIR99021 treatment of cells expressing wild‐type hSERT (hSERT‐WT) resulted in a time and dose‐dependent elevation of hSERT function with a concomitant increase in the Vmax and surface transporters because of reduced internalization and enhanced membrane insertion; silencing GSK3α/ß in these cells with siRNA also similarly affected hSERT. Converting putative GSK3α/ß phosphorylation site serine at position 48 to alanine in hSERT (hSERT‐S48A) completely abrogated the effects of both the inhibitor CHIR99021 and GSK3α/ß siRNA. Substantiating these findings, over‐expression of constitutively active GSK3ß with hSERT‐WT, but not with hSERT‐S48A, reduced SERT function, Vmax, surface density, and enhanced transporter phosphorylation. Both hSERT‐WT and hSERT‐S48A were inhibited similarly by PKC activation or by inhibition of Akt, CaMKII, p38 MAPK, or Src kinase. These findings provide new evidence that GSK3ß supports basal SERT function and trafficking via serine‐48 phosphorylation. image
Antidepressants in intensive care survivors: neuroimmune modulation, clinical outcomes, and translational implications D Ragu Varman, FA Jayakumar Journal of Clinical Anesthesia and Intensive care , 2026 2026
Microbiome Driven Modulation of Neurotransmitters: Implications for Neurotransmission and Mood Disorders BS Sivamaruthi, P Kesika, C Chaiyasut, D Ragu Varman Frontiers in Microbiology 17, 1750377 , 2026 2026
The Role of Oxytocin-Driven Synaptic Plasticity in Post-Traumatic Stress Disorder: Mechanisms, Therapeutic Potential, and Future Directions D Ragu Varman, BS Sivamaruthi, FA Jayakumar, N Rehman, R Raju, ... Current Pharmaceutical Design , 2026 2026
Environmental Contexts and the Neural Basis of Memory and Spatial Navigation. Subramanian, D., Sri, D. M., Jayakumar, F. A., Ragu Varman, Durairaj. European Journal of Clinical and Biomedical Sciences 12 (1), 7-16 , 2026 2026
The Dynorphin–Kappa Opioid System as a Salience Gatekeeper in Schizophrenia D Ragu Varman Journal of Experimental Neurology 7 (1), 49-54 , 2026 2026
Gut Dysbiosis in Neurodevelopmental Disorders: Linking Microbiota Signatures to Cognitive Rigidity in Autism Spectrum Disorder BS Sivamaruthi, K Periyanaina, C Chaiyasut, D Ragu Varman Frontiers in Microbiology 17, 1760635 , 2026 2026 Citations: 2
Causal Mechanisms of Monoamine Transporter Phosphorylation S Ramamoorthy, D Ragu Varman, LD Jayanthi Monoamine Transporters, 121-142 , 2025 2025 Citations: 1
Kappa opioid receptor antagonism restores phosphorylation, trafficking and behavior induced by a disease-associated dopamine transporter variant FP Mayer, A Stewart, D Ragu Varman, AE Moritz, JD Foster, AW Owens, ... Molecular psychiatry 30 (10), 4651-4664 , 2025 2025 Citations: 8
Discovery of natural orexin 2 receptor antagonists from Valeriana species: A potential approach for insomnia treatment AG Shenoy, V Ravi, S Subair, D Ragu Varman, R Raju, N Rehman Chronobiology International 42 (8), 1107-1120 , 2025 2025
Threonine-53 Phosphorylation of Dopamine Transporter Dictates κ-Opioid Receptor-Mediated Locomotor Suppression, Aversion, and Cocaine Reward D Ragu Varman, S Ramamoorthy, LD Jayanthi Journal of Neuroscience 45 (25) , 2025 2025 Citations: 3
Spontaneous calcium transients recorded from striatal astrocytes in a preclinical model of autism H Saavedra-Bonilla, D Ragu Varman, D Reyes-Haro Neurochemical Research 49 (11), 3069-3077 , 2024 2024 Citations: 5
Dopamine transporter threonine-53 phosphorylation dictates kappa opioid receptor mediated locomotor suppression and conditioned place aversion via transporter upregulation D Ragu Varman, LD Jayanthi, S Ramamoorthy bioRxiv, 2024.05. 09.593368 , 2024 2024
Prevalence of cardiovascular diseases in South Asians: scrutinizing traditional risk factors and newly recognized risk factors sarcopenia and osteopenia/osteoporosis HK Bhotla, A Meyyazhagan, K Pushparaj, M Pappuswamy, A Chaudhary, ... Current Problems in Cardiology 49 (1), 102071 , 2024 2024 Citations: 10
Striatal synaptic changes and behavior in adult mouse upon prenatal exposure to valproic acid A Hernandez, E Delgado-Gonzalez, D Ragu Varman, D Reyes-Haro, ... Brain Research 1815, 148461 , 2023 2023 Citations: 10
Kappa opioid receptor antagonism rescues genetic perturbation of dopamine homeostasis: Molecular, physiological and behavioral consequences FP Mayer, A Stewart, D Ragu Varman, AE Moritz, JD Foster, AW Owens, ... BioRxiv , 2023 2023 Citations: 6
Blunted amphetamine-induced reinforcing behaviors and transporter downregulation in Knock-in mice carrying alanine mutations at Threonine-258 and Serine-259 of norepinephrine … D Ragu Varman, P Mannangatti, MA Subler, JJ Windle, S Ramamoorthy, ... Journal of Molecular Neuroscience 72 (9), 1965-1976 , 2022 2022 Citations: 3
Neurokinin-1 antagonism distinguishes the role of norepinephrine transporter from dopamine transporter in mediating amphetamine behaviors P Mannangatti, D Ragu Varman, S Ramamoorthy, LD Jayanthi Pharmacology 106 (11-12), 597-605 , 2021 2021 Citations: 2
Novelty-induced hyperactivity and suppressed cocaine induced locomotor activation in mice lacking threonine 53 phosphorylation of dopamine transporter D Ragu Varman, MA Subler, JJ Windle, LD Jayanthi, S Ramamoorthy Behavioural brain research 408, 113267 , 2021 2021 Citations: 17
Kappa opioid receptor mediated differential regulation of serotonin and dopamine transporters in mood and substance use disorder D Ragu Varman, LD Jayanthi, S Ramamoorthy The Kappa Opioid Receptor, 97-112 , 2021 2021 Citations: 9
Inhibition of monoamine oxidase attenuates social defeat-induced memory impairment in goldfish,(Carassius auratus): a possible involvement of synaptic proteins and BDNF S Thangaleela, D Ragu Varman, K Sivasangari, KE Rajan Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology … , 2021 2021 Citations: 7
MOST CITED SCHOLAR PUBLICATIONS
Environmental enrichment reduces anxiety by differentially activating serotonergic and neuropeptide Y (NPY)-ergic system in Indian field mouse (Mus booduga): an animal model of … D Ragu Varman, KE Rajan PLoS One 10 (5), e0127945 , 2015 2015 Citations: 72
A Mutation in Hnrnph1 That Decreases Methamphetamine-Induced Reinforcement, Reward, and Dopamine Release and Increases Synaptosomal hnRNP H and … QT Ruan, N Yazdani, BC Blum, JA Beierle, W Lin, MA Coelho, EK Fultz, ... The Journal of Neuroscience 40 (1), 107-130 , 2020 2020 Citations: 59
Isolation, Characterization and Identification of a Potential Probiont from South Indian Fermented Foods (Kallappam, Koozh and Mor Kuzhambu) and Its Use as Biopreservative VA R. Satish Kumar, D. Ragu Varman, P. Kanmani, N. Yuvaraj, K. A. Paari, V ... Probiotics and Antimicrobial Proteins 2 (3), 143-151 , 2010 2010 Citations: 52
Environmental enrichment modulates glucocorticoid receptor expression and reduces anxiety in Indian field male mouse Mus booduga through up-regulation of microRNA-124a. D Ragu Varman, KE Rajan General and Comparitive endocrinology 199, 26-32 , 2014 2014 Citations: 33
Anorexia reduces GFAP+ cell density in the rat hippocampus D Reyes-Haro, FE Labrada-Moncada, D Ragu Varman, J Krüger, ... Neural Plasticity 2016 (1), 2426413 , 2016 2016 Citations: 28
Anorexia induces a microglial associated pro-inflammatory environment and correlates with neurodegeneration in the prefrontal cortex of young female rats P Reyes-Ortega, D Ragu Varman, VM Rodríguez, D Reyes-Haro Behavioural brain research 392, 112606 , 2020 2020 Citations: 27
Anorexia increases microglial density and cytokine expression in the hippocampus of young female rats D Ragu-Varman, M Macedo-Mendoza, FE Labrada-Moncada, ... Behavioural brain research 363, 118-125 , 2019 2019 Citations: 26
Glycogen synthase kinase-3ß supports serotonin transporter function and trafficking in a phosphorylation-dependent manner Ragu Varman, Durairaj, Lankupalle D. Jayanthi, Sammanda Ramamoorthy Journal of Neurochemistry , 2020 2020 Citations: 21
GABAρ3 expression in lobule X of the cerebellum is reduced in the valproate model of autism DR Varman, MB Soria-Ortíz, A Martínez-Torres, D Reyes-Haro Neuroscience letters 687, 158-163 , 2018 2018 Citations: 20
Environmental enrichment upregulates micro‐RNA‐183 and alters acetylcholinesterase splice variants to reduce anxiety‐like behavior in the little Indian field mouse (Mus booduga) D Ragu Varman, G Marimuthu, K Emmanuvel Rajan Journal of Neuroscience Research 91 (3), 426-435 , 2013 2013 Citations: 20
Histamine receptors regulate the activity, surface expression, and phosphorylation of serotonin transporters B Annamalai, D Ragu Varman, RE Horton, LC Daws, LD Jayanthi, ... ACS chemical neuroscience 11 (3), 466-476 , 2020 2020 Citations: 18
Novelty-induced hyperactivity and suppressed cocaine induced locomotor activation in mice lacking threonine 53 phosphorylation of dopamine transporter D Ragu Varman, MA Subler, JJ Windle, LD Jayanthi, S Ramamoorthy Behavioural brain research 408, 113267 , 2021 2021 Citations: 17
Activity-dependent expression of miR-132 regulates immediate-early gene induction during olfactory learning in the greater short-nosed fruit bat, Cynopterus sphinx M Mukilan, D Ragu Varman, S Sudhakar, KE Rajan Neurobiology of learning and memory 120, 41-51 , 2015 2015 Citations: 13
Egr-1 antisense oligodeoxynucleotide administration into the olfactory bulb impairs olfactory learning in the greater short-nosed fruit bat Cynopterus sphinx A Ganesh, W Bogdanowicz, K Balamurugan, D Ragu Varman, KE Rajan Brain research 1471, 33-45 , 2012 2012 Citations: 12
Environmental enrichment exerts anxiolytic effects in the Indian field mouse (Mus booduga) D Ragu Varman, G Marimuthu, KE Rajan Applied Animal Behaviour Science 136 (2-4), 166-173 , 2012 2012 Citations: 11
Prevalence of cardiovascular diseases in South Asians: scrutinizing traditional risk factors and newly recognized risk factors sarcopenia and osteopenia/osteoporosis HK Bhotla, A Meyyazhagan, K Pushparaj, M Pappuswamy, A Chaudhary, ... Current Problems in Cardiology 49 (1), 102071 , 2024 2024 Citations: 10
Striatal synaptic changes and behavior in adult mouse upon prenatal exposure to valproic acid A Hernandez, E Delgado-Gonzalez, D Ragu Varman, D Reyes-Haro, ... Brain Research 1815, 148461 , 2023 2023 Citations: 10
Ectoparasite Raymondia lobulata infestation in relation to the reproductive cycle of its host—the greater false vampire bat Megaderma lyra AA Sundari, W Bogdanowicz, D Ragu Varman, G Marimuthu, KE Rajan The Journal of parasitology 98 (1), 60-62 , 2012 2012 Citations: 10
Kappa opioid receptor mediated differential regulation of serotonin and dopamine transporters in mood and substance use disorder D Ragu Varman, LD Jayanthi, S Ramamoorthy The Kappa Opioid Receptor, 97-112 , 2021 2021 Citations: 9
Kappa opioid receptor antagonism restores phosphorylation, trafficking and behavior induced by a disease-associated dopamine transporter variant FP Mayer, A Stewart, D Ragu Varman, AE Moritz, JD Foster, AW Owens, ... Molecular psychiatry 30 (10), 4651-4664 , 2025 2025 Citations: 8